September 21, 2026 10:24 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Arvind Kejriwal, family ‘missing’ from Delhi voter list, claims Aam Aadmi Party | ‘No UPI above ₹2,000?’ Ghaziabad traders put up ‘cash only’ hoardings | Trump signs Russia sanctions bill: India faces fresh 100% tariff threat over Moscow oil | Caught using ChatGPT for exam answers, IIT Bombay student dies by suicide; students protest | Congress' Nandigram candidate arrested after Mamata's support amid TMC symbol row; Bengal bypoll gets chaotic | Gurugram murder shocker: Groom-to-be leaves sisters at Delhi restaurant to meet ex-colleague, found dead days later | Delhi horror: Teen allegedly gangraped, stabbed to death and dumped in field; dogs eat parts of body | TMC name, symbol frozen: EC tells rival factions to pick new identities ahead of Bengal bypolls | Married just 17 days ago: Hyderabad engineer mysteriously found dead at US home | ‘We will promote cash’: New UPI charge triggers trader backlash, Opposition protests

Genpact appoints Hanspeter Spek as Director

| | Apr 04, 2014, at 12:08 am
New York, Apr 3 (IBNS): Business process management company Genpact Limited on Thursday announced Hanspeter Spek as a member of its Board of Directors.
“We are honored to have Hanspeter join the Genpact Board. With his extensive global experience, he will bring significant value to Genpact and its Board,” said Robert Scott, Chairman of the Board, Genpact. 
 
Spek, who also currently serves as Chairman of the Board of Sanofi Germany, spent his career in the pharmaceutical industry where he most recently served as president of Global Operations at Sanofi S.A. before retiring in June 2013. 
 
Beginning his career at Pfizer, where he spent more than 10 years in increasingly responsible product and marketing management roles,Spek then joined Sanofi in 1985. 
 
His tenure there spanned a number of senior management roles including senior vice president of Europe following the merger with Synthélabo in 1999, director of Worldwide Operations of Sanofi-Synthélabo, and executive vice president of Global Pharmaceutical Operations for Sanofi-Aventis before he was promoted to president of Global Operations in 2009. 
 
A native of Germany, he currently resides in Paris.
 
“Genpact is thrilled to add another outstanding business leader to our Board. Hanspeter, who has had such a long and distinguished career in the pharmaceutical and life sciences industry, will bring great insights in one of our core focus industries,” said NV ‘Tiger’ Tyagarajan, president and CEO, Genpact. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.